nu-7441 and quizartinib

nu-7441 has been researched along with quizartinib* in 1 studies

Other Studies

1 other study(ies) available for nu-7441 and quizartinib

Article	Year
Quantitative phosphoproteomics uncovers synergy between DNA-PK and FLT3 inhibitors in acute myeloid leukaemia. Leukemia, 2021, Volume: 35, Issue:6 Topics: Benzothiazoles; Chromones; DNA-Activated Protein Kinase; Drug Synergism; Drug Therapy, Combination; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Morpholines; Phenylurea Compounds; Phosphoproteins; Proteome; Tumor Cells, Cultured	2021

Article

Year

Quantitative phosphoproteomics uncovers synergy between DNA-PK and FLT3 inhibitors in acute myeloid leukaemia.

Leukemia, 2021, Volume: 35, Issue:6

Topics: Benzothiazoles; Chromones; DNA-Activated Protein Kinase; Drug Synergism; Drug Therapy, Combination; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Morpholines; Phenylurea Compounds; Phosphoproteins; Proteome; Tumor Cells, Cultured

2021